Here, we demonstrated that NF-κB inhibitor Bay11-7082 decreased the secretion of IL-1β and IL-18 from leukemia cells and down-regulated the protein expression of pNF-κB, pro-caspase-1, pro-IL-1β, active caspase-1 and IL-1β. Here, CASP1 is linked to leukemia.